AssayIndex
Reports by quarter

Reports submitted in 2025-Q1 · page 17

Anomaly rule set expanded from seven rules to eleven. Median purity for the quarter is 99.14 % area, n=664. Read the 2025-Q1 state-of-the-index report →

672 records17 pagesmedian on this page 99.42 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-019760SemaglutideHomopeptideHOMO-2501-D4523PeptideMeter2025-Q199.465.7492.7Buyer-sourced0PASS
AX-2025-019661AfamelanotideTFCTFC-2502-Y2346Janoshik2025-Q199.294.55—Buyer-sourced1MARGINAL
AX-2025-018849DihexaFGPFGP-2408-S8496Kestrel2025-Q199.566.94—Buyer-sourced0PASS
AX-2025-021131EpitalonSIGSIG-2412-6325Nordanalyt2025-Q199.027.6690.7Buyer-sourced0FAIL
AX-2025-020019AOD-9604SWBSWB-2502-N7040PeptideMeter2025-Q198.884.8494.3Buyer-sourced0PASS
AX-2025-019644GHRP-2TFCTFC-2502-D2333Janoshik2025-Q199.645.17105.6Buyer-sourced0PASS
AX-2025-018998HexarelinASYASY-{CAT}-1786PeptideMeter2025-Q199.924.90—Buyer-sourced0PASS
AX-2025-020643TirzepatideGL BiochemGLBI-2412-R8446Janoshik2025-Q198.814.8898.6Buyer-sourced0PASS
AX-2025-019683DihexaTFCTFC-2409-U2263Janoshik2025-Q199.917.6096.0Buyer-sourced0PASS
AX-2025-019143TesamorelinGSPGSP-2501-G3708PeptideMeter2025-Q198.074.59—Buyer-sourced0PASS
AX-2025-021178SS-31 (Elamipretide)PPGPPG-2411-D6795Janoshik2025-Q199.716.18—Buyer-sourced0PASS
AX-2025-021172SS-31 (Elamipretide)PPGPPG-2411-D6795Janoshik2025-Q199.935.42—Buyer-sourced0PASS
AX-2025-020838IpamorelinCPCCPC-2503-J1794VendorInvestigate2025-Q197.866.54106.9Buyer-sourced0FAIL
AX-2025-019192CJC-1295 with DACSinoPepSNP-2412-E4702Janoshik2025-Q198.543.09—Buyer-sourced0PASS
AX-2025-019148TesamorelinGSPGSP-2501-G3708PeptideMeter2025-Q198.293.94—Buyer-sourced0PASS
AX-2025-020501SermorelinKPKP-2501-V5712Nordanalyt2025-Q198.305.49105.2Buyer-sourced1MARGINAL
AX-2025-019778BPC-157HomopeptideHOMO-2411-K4425Janoshik2025-Q199.883.70107.4Buyer-sourced0PASS
AX-2025-019530IpamorelinTFCTFC-2408-T9161Kestrel2025-Q199.384.1189.7Buyer-sourced2FAIL
AX-2025-019193CJC-1295 with DACSinoPepSNP-2412-E4702VendorInvestigate2025-Q198.282.68—Buyer-sourced0PASS
AX-2025-019045N-Acetyl Semax AmideASYASY-{CAT}-2147Janoshik2025-Q199.938.16102.4Buyer-sourced0PASS
AX-2025-020224SemaglutideGGPepsGGPE-2501-W1875Janoshik2025-Q198.135.73—Buyer-sourced0PASS
AX-2025-019956TB-500HJHJ-2501-A6454Kestrel2025-Q199.804.8898.6Laboratory-retained2FAIL
AX-2025-019613GHRP-2TFCTFC-2411-A2083PeptideMeter2025-Q199.782.62104.0Buyer-sourced0PASS
AX-2025-018836CJC-1295 (no DAC)FGPFGP-2503-P8516VendorInvestigate2025-Q198.985.84—Buyer-sourced0PASS
AX-2025-018665TirzepatideQSCQSC-2410-R5814PeptideMeter2025-Q199.835.00—Buyer-sourced0PASS
AX-2025-020903MK-677 (Ibutamoren mesylate)WXTWXT-2502-F2050Janoshik2025-Q199.624.12100.8Buyer-sourced0FAIL
AX-2025-018764BPC-157QSCQSC-2412-D7527Janoshik2025-Q199.336.6893.4Buyer-sourced0PASS
AX-2025-019648GHRP-2TFCTFC-2502-D2333Medutest2025-Q199.415.67—Buyer-sourced1FAIL
AX-2025-020188BPC-157ERPERP-2502-P9890Janoshik2025-Q199.643.7490.9Buyer-sourced0PASS
AX-2025-021179SS-31 (Elamipretide)PPGPPG-2411-D6795Janoshik2025-Q199.655.4589.8Buyer-sourced1MARGINAL
AX-2025-018637TirzepatideQSCQSC-2408-T5296Medutest2025-Q199.435.27101.9Buyer-sourced0PASS
AX-2025-018425SemaglutideWWBWWB-2501-S2183PeptideMeter2025-Q198.763.49—Buyer-sourced0PASS